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Abstract           
Aiming at the improvement of the photorelease of butyric acid - a model carboxylic acid drug, a set 
of heteroaromatic compounds based on acridine, naphtho[2,1-b]pyran, 3H-benzopyran fused 
julolidine and thioxo-naphtho[2,1-b]pyran were evaluated as benzyl-type phototriggers, in 
comparison with the well-known o-nitrobenzyl group. The corresponding ester cages were irradiated 
in a photochemical reactor at 254, 300, 350 and 419 nm, in two solvent systems (methanol or 
acetonitrile in 80:20 mixtures with HEPES buffer). Photolysis studies showed that, for some of the 
cages, the release of the active molecule occurred with short irradiation times at 419 nm. Time-
resolved fluorescence was used to elucidate their photophysical properties and determine the decay 
kinetics. Studies were also carried out to assess the suitability of using two-photon excitation to 
address these compounds, which is advantageous if their use in biological systems is to be 
considered. 
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1. Introduction 
The use of several drugs in clinical practice is dependent on the improvement of their therapeutic 
effects, bioavailability, physicochemical properties and the minimizing of other undesirable side 
effects. Prodrugs, pharmacologically latent derivatives of active agents, can be designed to undergo
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 activation through a specific stimulus. In addition to chemical and/or enzymatic triggers, light is an 
appealing tool to use for conversion of prodrugs to active agents in a spatially and temporally 
controlled manner [1-8]. Butyric acid, a saturated unbranched monocarboxylic acid, is one of the 
short-chain fatty acids. The effects of butyric acid include the disruption of cell proliferation and 
induction of apoptosis; modification of cell morphology and alteration of gene expression [9]. The 
presence of carboxylic acids or other ionisable polar groups in drugs can result in poor absorption 
from the gastrointestinal tract owing to lipophilicity/solubility issues. 
 
Light triggerable benzyl or heterocyclic benzyl esters represent a large family of photolabile 
protecting groups. o-Nitrobenzylic derivatives have been widely used in various applications, as they 
combine a satisfactory photosensitivity with a stability for handling and synthesis purposes [10-12]. 
Nevertheless, o-nitrobenzyl cages exhibit some limitations, since the wavelength of excitation 
required for the uncaging is not necessarily the most suitable for bioapplications. The search for 
protecting groups with improved photochemical properties and even displaying fluorescence has 
motivated the incorporation of heterocyclic moieties in their design, with coumarinyl methyl groups 
as relevant examples. It is possible to find a wide range of derivatives possessing different 
combinations of substituents and/or fusion ring units for the release of various active molecules [13-
15]. Recently, acridinyl methyl esters have also proved to possess the required photosensitivity for 
the release of carboxylic acid compounds [16].  
 
Considering the know-how of the authors in the field of fluorescent photoactivable molecules based 
on aromatic and heteroaromatic skeletons for the release of bioanalytes [17-24], in connection with 
the interest in the development of alternative light sensitive prodrugs, and following the previous 
work regarding butyric acid, a new set of oxygen and nitrogen heterocyclic cages were synthesised. 
The use of these heterocyclic moieties can produce longer maximum wavelengths of absorption, 
allowing the photorelease of butyric acid at longer wavelengths, not detrimental to bioapplications.  
It also opens the way to use two-photon excitation (TPE), where if sufficient photon flux is present 
two longer wavelength photons can be used to excite a sample. This is advantageous as it only occurs 
in a fentolitre volume and the longer wavelength photons are less likely to interact with biological 
material.  Thus, the present work evaluates the behaviour of (acridin-9-yl)methyl, (5-methoxy-3-oxo-
3H-naphtho[2,1-b]pyran-1-yl)methyl, (8-methoxy-3-oxo-3H-naphtho[2,1-b]pyran-1-yl)methyl, and 
[11-oxo-2,3,5,6,7,11-hexahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-9-yl]methyl groups, in 
comparison with the well-known o-nitrobenzyl group in the light-induced release of butyric acid. 
Additionally, bearing in mind that the replacement of a carbonyl by a thiocarbonyl group results in 
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an improvement in the photolytic release [23,24], thionated groups; namely (5-methoxy-3-thioxo-
3H-naphtho[2,1-b]pyran-1-yl)methyl, (8-methoxy-3-thioxo-3H-naphtho[2,1-b]pyran-1-yl)methyl, 
and (9-methoxy-3-thioxo-3H-naphtho[2,1-b]pyran-1-yl)methyl were tested. The ester cages, in two 
solvent systems (methanol or acetonitrile in 80:20 mixtures with HEPES buffer), were irradiated at 
254, 300, 350 and 419 nm in a photochemical reactor. The fact that the groups exhibit fluorescence 
enabled time-resolved fluorescence measurements to be employed to elucidate their photophysical 
properties and determine the decay kinetics, along with their suitability for two-photon excitation. 
This last point can be important if their use in biological systems is to be considered 
 
2. Experimental  
 
2.1. Synthesis general 
All melting points were measured on a Stuart SMP3 melting point apparatus. TLC analyses were 
carried out on 0.25 mm thick precoated silica plates (Merck Fertigplatten Kieselgel 60F254) and spots 
were visualised under UV light. Chromatography on silica gel was carried out on Merck Kieselgel 
(230-240 mesh). IR spectra were determined on a BOMEM MB 104 spectrophotometer. UV/visible 
absorption spectra (200 ± 700 nm) were obtained using a Shimadzu UV/2501PC spectrophotometer. 
NMR spectra were obtained on a Bruker Avance III 400 at an operating frequency of 400 MHz for 
1H and 100.6 MHz for 13C using the solvent peak as internal reference at 25 ºC. All chemical shifts 
are given in ppm using įH Me4Si = 0 ppm as reference and J values are given in Hz. Assignments 
were made by comparison of chemical shifts, peak multiplicities and J values and were supported by 
spin decoupling-double resonance and bidimensional heteronuclear correlation techniques.  Mass 
VSHFWURPHWU\DQDO\VHVZHUHSHUIRUPHGDWWKH³&$&7,- 8QLGDGGH(VSHFWURPHWULDGH0DVDV´DW
University of Vigo, Spain. Fluorescence spectra were collected using a FluoroMax-4 
spectrofluorometer. All reagents were used as received. Compounds 5, 6 and 11 were synthesised as 
previously reported [20,25,26]. 
 
2.2. Synthesis of 1-chloromethyl-5-methoxy-3-oxo-3H-naphtho[2,1-b]pyran 3. To a solution of 3-
methoxy-2-naphthol (0.104 g, 5.97 u 10-4 mol) in 70% aqueous sulphuric acid (5 mL), ethyl 4-
chloro-3-oxobutanoate (0.089 mL, 6.57 u 10-4 mol) was added. The reaction was followed by TLC 
(ethyl acetate/n-hexane, 1:4), and stirred at room temperature for 96 h. The mixture was poured into 
ice water and stirred for 2 h to give a fine pale precipitate. The solid was collected by filtration, 
washed with cold water, dried and purified by column chromatography, using ethyl acetate/ light 
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petroleum as eluent, with mixtures of increasing polarity. Compound 3 was obtained as pale brown 
solid (0.012 g, 7%). Mp 169.5-171.8 °C. Rf = 0.50 (ethyl acetate/n-hexane, 1:4). 1H NMR (400 MHz, 
CDCl3): įH = 4.03 (s, 3 H, OCH3), 5.05 (s, 2 H, CH2), 6.75 (s, 1 H, H-2), 7.36 (s, 1 H, H-6), 7.54-
7.57 (m, 2 H, H-8 and H-9), 7.82-7.84 (m, 1 H, H-7), 8.30-8.32 (m, 1 H, H-10). 13C NMR (100.6 
MHz, CDCl3): įC = 45.79 (CH2), 56.16 (OCH3), 111.17 (C-6), 113.51 (C-4b), 117.74 (C-2), 123.69 
(C-6b), 124.71 (C-10), 125.95 (C-9), 126.17 (C-8), 128.46 (C-7), 131.25 (C-6a), 146.75 (C-5), 
147.21 (C-4a), 151.33 (C-1), 159.22 (C-3). IR (KBr 1%): Ȟ= 1728, 1627, 1599, 1556, 1513, 1486, 
1462, 1439, 1422, 1378, 1348, 1325, 1264, 1217, 1168, 1140, 1122, 1046, 1024, 1001, 938, 896, 
866, 844, 778, 737, 704 cm-1. HRMS (ESI) for C15H1237ClO3 [M++H]: calculated 277.04456, found 
277.04478; for C15H1235ClO3 [M++H]: calculated 275.04756, found 275.04770. 
 
2.3. Synthesis of 1-chloromethyl-8-methoxy-3-oxo-3H-naphtho[2,1-b]pyran 4.To a solution of 6-
methoxy-2-naphthol (0.248 g, 1.42 u 10-3 mol) in 70% aqueous sulphuric acid (5 mL), ethyl 4-
chloro-3-oxobutanoate (0.288 mL, 2.13 u 10-3 mol) was added. The reaction was followed by TLC 
(ethyl acetate/n-hexane, 1:4), and stirred at room temperature for 72 h. The mixture was poured into 
ice water and stirred for 2 h to give a fine pale precipitate. The solid was collected by filtration, 
washed with cold water, dried and purified by column chromatography, using ethyl acetate/light 
petroleum as eluent, with mixtures of increasing polarity. Compound 4 was obtained as pale yellow 
solid (0.145 g, 37%). Mp 207.3-209.9 °C. Rf = 0.50 (ethyl acetate/n-hexane, 1:4). 1H NMR (400 
MHz, CDCl3): įH = 3.97 (s, 3 H, OCH3), 5.03 (s, 2 H, CH2), 6.72 (s, 1 H, H-2), 7.26 (d, J = 2.8 Hz, 1 
H, H-7), 7.36 (dd, J = 9.6 and 2.8 Hz, 1 H, H-9), 7.46 (d, J = 8.8 Hz, 1 H, H-5), 7.92 (d, J = 8.8 Hz, 1 
H, H-6), 8.33 (d, J = 9.2 Hz, 1 H, H-10). 13C NMR (100.6 MHz, CDCl3): įC = 45.84 (CH2), 55.41 
(OCH3), 108.61 (C-7), 112.70 (C-4b), 117.51 (C-2), 118.18 (C-5), 120.09 (C-9), 123.44 (C-6b), 
126.36 (C-10), 132.97 (C-6a), 133.16 (C-6), 150.98 (C-1), 153.76 (C-4a), 157.13 (C-8), 160.09 (C-
3). IR (KBr 1%): Ȟ = 1722, 1611, 1553, 1514, 1468, 1422, 1362, 1318, 1264, 1213, 1182, 1154, 
1118, 1034, 1015, 998, 912, 897, 878, 858, 816, 737, 704 cm-1. HRMS (ESI) for C15H1237ClO3 
[M++H]: calculated 277.04456, found 277.04449; for C15H1235ClO3 [M++H]: calculated 275.04756, 
found 275.04751. 
 
2.4. Synthesis of 2-nitrobenzyl butyrate, 7. To a solution of butyric acid (0.263 mL, 2.88 u 10-3 mol) 
in dry DMF (4 mL) at 0 °C, 1-hydroxybenzotriazole (HOBt) (0.072 g, 5.33 u 10-4 mol) was added. 
After stirring for 10 min, 11¶-dicyclohexylcarbodiimide (DCC) (0.114 g, 5.52 u 10-4 mol) was 
added, followed by (2-nitrophenyl)methanol 1 (0.402 g, 2.62 u 10-3 mol). The reaction mixture was 
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stirred at room temperature for 72 h and followed by TLC (ethyl acetate/light petroleum, 1:4). The 
solid was filtered and the residue was evaporated under vacuum. Cold acetone was added and the 
dicyclohexylurea precipitate was filtered. The solvent was removed by rotary evaporation under 
reduced pressure and the crude residue was purified by column chromatography using ethyl 
acetate/light petroleum, with mixtures of increasing polarity as eluent. Compound 7 was obtained as 
an orange oily solid (0.169 g, 29 %). Rf = 0.88 (ethyl acetate/light petroleum, 1:4). 1H NMR (400 
MHz, CDCl3): įH = 0.92 (t, J = 7.6 Hz, 3 H, CH3-CH2-CH2), 1.65 (sext, J = 7.2 Hz, 2 H, CH3-CH2-
CH2), 2.36 (t, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 5.47 (s, 2 H, CH2), 7.44 (dt, J = 7.4 and 1.6 Hz, 1 H, 
H-4), 7.55 (dd, J = 7.6 and 0.8 Hz, 1 H, H-6), 7.62 (dt, J = 7.4 and 0.8 Hz, 1 H, H-5), 8.02 (dd, J = 
8.0 and 0.8 Hz, 1 H, H-3). 13C NMR (100.6 MHz, CDCl3): įC = 13.43 (CH3-CH2-CH2), 18.19 (CH3-
CH2-CH2), 35.80 (CH3-CH2-CH2), 62.54 (CH2), 124.79 (C-3), 128.56 (C-4), 128.84 (C-6), 132.06 
(C-1), 133.54 (C-5), 147.39 (C-2), 172.80 (C=O). IR (KBr 1%): Ȟ = 2964, 2931, 2851, 1711, 1613, 
1574, 1525, 1476, 1445, 1434, 1366, 1338, 1305, 1251, 1187, 1144, 1085, 1037, 989, 858, 792, 726 
cm-1.  HRMS (ESI) for C11H14NO4 [M++H]: calculated 224.09232, found: 224.09240. 
 
2.5. Synthesis of (acridin-9-yl)methyl butyrate, 8. To a solution of 9-(bromomethyl)acridine 2 (0.038 
g, 1.39 u 10-4 mol) in dry DMF (3 mL) potassium fluoride (0.073 g, 4.17 u 10-4 mol) and butyric acid 
(0.014 mL, 1.52 u 10-4 mol) were added. The reaction was followed by TLC (ethyl acetate/light 
petroleum, 1:1), and stirred at room temperature for 15 h. The solvent was removed by rotary 
evaporation under reduced pressure and the crude residue was purified by column chromatography 
using ethyl acetate/light petroleum, mixtures of increasing polarity as eluent. Compound 8 was 
obtained as a brown oily solid (0.027 g, 69%). Rf = 0.48 (ethyl acetate/light petroleum, 1:1).  1H 
NMR (400 MHz, CDCl3): įH = 0.89 (t, J = 7.2 Hz, 3 H, CH3-CH2-CH2), 1.63 (sext, J = 7.2 Hz, 2 H, 
CH3-CH2-CH2), 2.32 (t, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 6.12 (s, 2 H, CH2), 7.62 (dt, J = 7.6 and 1.2 
Hz, 2 H, H-2 and H-7), 7.79 (dt, J = 7.8 and 1.2 Hz, 2 H, H-3 and H-6), 8.28 (d, J = 8.6 Hz, 2 H, H-4 
and H-5), 8.34 (d, J = 9.0 Hz, 2 H, H-1 and H-8). 13C NMR (100.6 MHz, CDCl3): įC = 13.54 (CH3-
CH2-CH2), 18.34 (CH3-CH2-CH2), 35.96 (CH3-CH2-CH2), 57.31 (CH2), 124.03 (C-1 and C-8), 
125.32 (C-8a and C-9a), 126.68 (C-2 and C-7), 129.97 (C-4 and C-5), 130.08 (C-3 and C-6), 137.53 
(C-9), 148.46 (C-4a and C-4b), 173.42 (C=O). IR (KBr 1%): Ȟ = 3067, 2965, 2934, 2875, 1737, 
1692, 1629, 1603, 1557, 1519, 1498, 1461, 1441, 1416, 1382, 1352, 1303, 1286, 1249, 1165, 1100, 
1058, 1040, 1018, 976, 911, 862, 753, 733, 643 cm-1. HRMS (ESI) for C18H18NO2 [M++H]: 
calculated 280.13384, found: 280.13403. 
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2.6. Synthesis of (5-methoxy-3-oxo-3H-naphtho[2,1-b]pyran-1-yl)methyl butyrate, 9. To a solution of 
1-chloromethyl-5-methoxy-3-oxo-3H-naphtho[2,1-b]pyran 3 (0.100 g, 3.64 u 10-4 mol) in dry DMF 
(4 mL), potassium fluoride (0.063 g, 1.09 u 10-3 mol) and butyric acid (0.033 mL, 3.64 u 10±4 mol) 
were added. The reaction was followed by TLC (ethyl acetate/light petroleum, 1:4), and stirred at 
room temperature for 42 h. The solvent was removed by rotary evaporation under reduced pressure 
and the crude residue was purified by column chromatography using mixtures of ethyl acetate/light 
petroleum as eluent. Compound 9 was obtained as an oily solid (0.083 g, 70%). Rf = 0.22 (ethyl 
acetate/light petroleum, 1:4). 1H NMR (400 MHz, CDCl3): įH = 1.01 (t, J = 7.2 Hz, 3 H, CH3-CH2-
CH2), 1.70-1.80 (m, 2 H, CH3-CH2-CH2), 2.48 (t, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 4.04 (s, 3H, 
OCH3), 5.64 (d, J = 1.2 Hz, 2 H, CH2), 6.70 (t, J = 1.2 Hz, 1 H, H-2), 7.30 (s, 1 H, H-6), 7.47-7.53 
(m, 2 H, H-8 and H-9), 7.76-7.81 (m, 1 H, H-10), 7.95-8.10 (m, 1 H, H-7). 13C NMR (100.6 MHz, 
CDCl3): įC = 13.62 (CH3-CH2-CH2), 18.32 (CH3-CH2-CH2), 35.95 (CH3-CH2-CH2), 56.06 (OCH3), 
63.94 (CH2), 110.81 (C-6), 113.14 (C-2), 113.43 (C-4b), 123.94 (C-6b), 124.40 (C-7), 125.89 (C-8), 
125.98 (C-9), 128.42 (C-10), 131.09 (C-6a), 146.65 (C-4a), 146.81 (C-5), 151.46 (C-1), 159.43 (C-
3), 172.65 (C=O). IR (KBr 1%): Ȟ = 3426, 3060, 2964, 2878, 2836, 1733, 1627, 1599, 1559, 1513, 
1460, 1425, 1346, 1322, 1264, 1147, 1121, 1085, 1005, 932, 864, 835, 780, 738, 703 cm±1. HRMS 
(ESI) for C19H19O5 [M++H]: calculated 327.12327, found: 327.12356. 
 
2.7. Synthesis of (8-methoxy-3-oxo-3H-naphtho[2,1-b]pyran-1-yl)methyl butyrate, 10. To a solution 
of 1-chloromethyl-8-methoxy-3-oxo-3H-naphtho[2,1-b]pyran 4 (0.305 g 1.11 u 10-3 mol) in dry 
DMF (5 mL), potassium fluoride (0.193 g, 3.33 u 10-3 mol) and butyric acid (0.101 mL, 1.11 u 10-3 
mol) were added. The reaction was followed by TLC (ethyl acetate/light petroleum, 1:4), and stirred 
at room temperature for 44 h. The solvent was removed by rotary evaporation under reduced 
pressure and the crude residue was purified by column chromatography using mixtures of ethyl 
acetate/light petroleum as eluent. Compound 10 was obtained as oil (0.257 g, 71%). Rf = 0.28 (ethyl 
acetate/light petroleum, 1:4). 1H NMR (400 MHz, CDCl3): įH = 0.99 (t, J = 7.2 Hz, 3 H, CH3-CH2-
CH2), 1.69-1.78 (m, 2 H,
 
CH3-CH2-CH2), 2.45 (t, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 3.90 (s, 3H, 
OCH3), 5.52 (d, J  = 1.2 Hz, 2 H, CH2), 6.58 (t, J = 1.2 Hz, 1H, H-2), 7.14 (d, J =  2.4 Hz, 1 H, H-7), 
7.22 (dd, J =  9.2 and 2.8 Hz, 1 H, H-9), 7.31 (d, J = 9.2 Hz, 1 H, H-10), 7.78 (d, J = 8.8 Hz, 1 H, H-
5), 7.87 (d, J = 9.6 Hz, 1H, H-6). 13C NMR (100.6 MHz, CDCl3): įC = 13.54 (CH3-CH2-CH2), 18.22 
(CH3-CH2-CH2), 35.82 (CH3-CH2-CH2), 55.22 (OCH3), 63.78 (CH2), 108.43 (C-7), 112.43 (C-4b), 
112.72 (C-2), 117.89 (C-10), 119.86 (C-9), 123.50 (C-6b), 125.86 (C-6), 132.62 (C-5), 132.66 (C-1), 
150.91 (C-4a), 153.14 (C-6a), 156.82 (C-8), 160.05 (C-3), 172.52 (C=O). IR (neat): Ȟ= 3425, 2965, 
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2877, 2840, 1725, 1614, 1556, 1519, 1468, 1364, 1308, 1249, 1205, 1170, 1122, 1086, 1035, 999, 
916, 857, 812, 734, 700, 675 cm
-1
. HRMS (ESI) for C19H19O5 [M++H]: calculated 327.12327, found: 
327.12319. 
 
2.8. Synthesis of (11-oxo-2,3,5,6,7,11-hexahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-9-
yl)methyl butyrate, 12. To a solution of 9-(chloromethyl)-2,3,6,7-tetrahydro-1H-pyrano[2,3-
f]pyrido[3,2,1-ij]quinolin-11(5H)-one 6 (0.042 mg, 1.45 u 10-4 mol) in dry DMF (4 mL), potassium 
fluoride (0.025 g, 4.35 u 10-4 mol) and butyric acid (0.014 mL, 1.59 u 10-4 mol) were added. The 
reaction was followed by TLC (ethyl acetate/light petroleum, 1:4), and stirred at room temperature 
for 14 h. The solvent was removed by rotary evaporation under reduced pressure and the crude 
residue was purified by column chromatography using mixtures of ethyl acetate/light petroleum as 
eluent. Compound 12 was obtained as oil (0.017 g, 34 %). Rf = 0.58 (ethyl acetate/light petroleum, 
1:4). 1H NMR (400 MHz, CDCl3): įH = 0.99 (t, J = 7.2 Hz, 3 H, CH3-CH2-CH2), 1.73 (sext, J = 7.2 
Hz, 2 H, CH3-CH2-CH2), 1.91-2.03 (m, 4H, H-2 and H-6), 2.42 (t, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 
2.76 (t, J = 6.4 Hz, 2 H, H-7), 2.89 (t, J = 6.4 Hz, 2 H, H-1), 3.18-3.33 (m, 4 H, H-3 and H-5), 5.20 
(s, 2 H, CH2), 6.10 (s, 1 H, H-10), 6.88 (s, 1 H, H-8). 13C NMR (100.6 MHz, CDCl3): įC = 13.66 
(CH3-CH2-CH2), 18.37 (CH3-CH2-CH2), 20.39 (C-2), 20.55 (C-1), 21.45 (C-6), 27.67 (C-7), 36.00 
(CH3-CH2-CH2), 49.48 (C-3), 49.88 (C-5), 61.17 (CH2), 105.49 (C-10), 105.80 (C-8a), 106.96 (C-
12b), 118.20 (C-7a), 120.40 (C-8), 145.95 (C-7b), 149.68 (C-9), 151.17 (C-12a), 162.26 (C-11), 
172.93 (C=O). IR (neat): Ȟ= 2958, 2933, 2873, 2856, 1720, 1605, 1558, 1522, 1437, 1382, 1343, 
1312, 1203, 1174, 1124, 1075, 1019, 884, 851, 753, 738, 701 cm-1.  HRMS (ESI) for C20H24NO4 
[M++H]: calculated 342.17062, found: 342.17031. 
 
2.9. Synthesis of (5-methoxy-3-thioxo-3H-naphtho[2,1-b]pyran-1-yl)methyl butyrate, 13. /DZHVVRQ¶V
reagent (0.268 g, 6.62 × 10-4 mol) was added to a solution of (5-methoxy-3-oxo-3H-naphtho[2,1-
b]pyran-1-yl)methyl butyrate 9 (0.072 g, 2.20 × 10-4 mol) in toluene (8 mL). The reaction mixture 
was refluxed for 9 h and the process was followed by TLC (ethyl acetate/light petroleum, 1:4). The 
solvent was removed by rotary evaporation under reduced pressure and the crude residue was 
purified by column chromatography using dichlorometane/light petroleum mixtures of increasing 
polarity as eluent. Compound 13 was obtained as oil (0.004 g, 5 %). Rf = 0.71 (ethyl acetate/light 
petroleum, 1:4). 1H NMR (400 MHz, CDCl3): įH = 1.02 (t, J = 7.2 Hz, 3 H, CH3-CH2-CH2), 1.70-
1.81 (m, 2 H, CH3-CH2-CH2), 2.50 (t, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 4.10 (s, 3 H, OCH3), 5.66 (d, 
J = 1.2 Hz, 2 H, CH2), 7.39 (s, 1 H, H-6), 7.52-7.62 (m, 3 H, H-2, H-8 and H-9), 7.81-7.86 (s, 1 H, 
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H-7), 8.03-8.10 (m, 1 H, H-10). 13C NMR (100.6 MHz, CDCl3): įC = 13.66 (CH3-CH2-CH2), 18.39 
(CH3-CH2-CH2), 35.99 (CH3-CH2-CH2), 56.24 (OCH3), 63.76 (CH2), 111.27 (C-6), 116.07 (C-4b), 
123.76 (C-6b), 125.02 (C-10), 126.24 (C-9), 126.73 (C-8), 127.80 (C-2), 128.57 (C-7), 131.63 (C-
6a), 142.49 (C-1), 146.33 (C-5), 150.29 (C-4a), 172.78 (C=O), 194.49 (C-3). IR (neat): Ȟ = 2964, 
2932, 2875, 1738, 1623, 1593, 1545, 1513, 1460, 1425, 1323, 1297, 1256, 1233, 1218, 1164, 1125, 
1104, 1004, 913, 866, 835, 778, 739 cm±1. HRMS (ESI): calculated for C19H19O4S [M++H]: 
343.10047, found: 343.10079. 
 
2.10. Synthesis of (8-methoxy-3-thioxo-3H-naphtho[2,1-b]pyran-1-yl)methyl butyrate, 14. 
/DZHVVRQ¶V UHDJHQW  J u 10-4 mol) was added to a solution of (8-methoxy-3-oxo-3H-
naphtho[2,1-b]pyran-1-yl)methyl butyrate 10 (0.103 g, 3.16 u 10-4 mol) in toluene (8 mL). The 
reaction mixture was refluxed for 23 h and followed by TLC (ethyl acetate/light petroleum, 1:4). The 
solvent was removed by rotary evaporation under reduced pressure and the crude residue was 
purified by column chromatography using ethyl acetate/light petroleum mixtures of increasing 
polarity as eluent. Compound 14 was obtained as an orange solid (0.087 g, 80%). M.p. 144.9±146.5 
ºC. Rf = 0.64 (ethyl acetate/light petroleum, 1:4). 1H NMR (400 MHz, CDCl3): įH = 1.02 (t, J = 7.2 
Hz, 3 H, CH3-CH2-CH2), 1.70-1.80 (m, 2 H, CH3-CH2-CH2), 2.49 (t, J = 7.2 Hz, 2 H, CH3-CH2-
CH2), 3.96 (s, 3 H, OCH3), 5.57 (d, J = 0.8 Hz, 2 H, CH2), 7.24 (d, J = 2.8 Hz, 1 H, H-7), 7.29-7.35 
(m, 1 H, H-9), 7.51 (s, 1 H, H-2), 7.55 (d, J = 9.2 Hz, 1 H, H-10), 7.91 (d, J = 9.2 Hz, 1 H, H-5), 8.02 
(d, J = 9.6 Hz, 1 H, H-6). 13C NMR (100.6 MHz, CDCl3): įC = 13.63 (CH3-CH2-CH2), 18.34 (CH3-
CH2-CH2), 35.93 (CH3-CH2-CH2), 55.43 (OCH3), 63.66 (CH2), 108.83 (C-7), 115.09 (C-4b), 117.77 
(C-10), 120.24 (C-9), 123.26 (C-6b), 126.60 (C-6), 127.22 (C-2), 133.23 (C-6a), 133.39 (C-5), 
142.29 (C-1), 156.87 (C-4a), 157.56 (C-8), 172.71 (C=O), 195.02 (C-3). IR (KBr 1%): Ȟ = 3061, 
2961, 2877, 1903, 1743, 1609, 1542, 1524, 1468, 1454, 1426, 1367, 1292, 1266, 1208, 1163, 1139, 
1097, 1035, 978, 936, 908, 858, 810, 736 cm-1. HRMS (ESI) for C19H19O4S [M++H]: calculated 
343.10047, found: 343.10096. 
 
2.11. Synthesis of (9-methoxy-3-thioxo-3H-naphtho[2,1-b]pyran-1-yl)methyl butyrate, 15. 
/DZHVVRQ¶V UHDJHQW  J, 4.11 u 10-4 mol) was added to a solution of (9-methoxy-3-oxo-3H-
benzo[f]benzopyran-1-yl)methyl butyrate, 11 (0.067g, 2.05 u 10-4 mol) in toluene (5 mL). The 
reaction mixture was heated at reflux for 48 h and the process was followed by TLC (ethyl acetate/ 
light petroleum, 1:4). The solvent was removed by rotary evaporation under reduced pressure and the 
crude residue was purified by column chromatography using ethyl acetate/light petroleum, with 
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mixtures of increasing polarity as eluent. Compound 15 was obtained as an orange solid (0.049 g, 
70%). Mp 132.5-134.7 ºC. Rf = 0.86 (ethyl acetate/light petroleum, 1:4). 1H NMR (400 MHz, 
CDCl3): įH = 1.01 (t, J = 7.2 Hz, 3 H, CH3-CH2-CH2), 1.75 (sext, J = 7.2 Hz, 2 H, CH3-CH2-CH2), 
2.49 (t, J = 7.6 Hz, 2 H, CH3-CH2-CH2), 3.97 (s, 3 H, OCH3), 5.60 (s, 2 H, CH2), 7.24 (dd, J = 8.8 
and 2.4 Hz, 1 H, H-8), 7.43 (d, J = 9.2 Hz, 1 H, H-5), 7.48 (d, J = 2.4 Hz, 1 H, H-10), 7.49 (s, 1 H, 
H-2), 7.83 (d, J = 8.8 Hz, 1 H, H-7), 7.93 (d, J = 8.8 Hz, 1 H, H-6). 13C NMR (100.6 MHz, CDCl3): 
įC = 13.63 (CH3-CH2-CH2), 18.28 (CH3-CH2-CH2), 35.92 (CH3-CH2-CH2), 55.47 (OCH3), 63.69 
(CH2), 106.25 (C-10), 114.30 (C-4b), 114.90 (C-5), 117.22 (C-8), 126.56 (C-6a), 126.97 (C-2), 
130.29 (C-6b), 131.38 (C-7), 134.25 (C-6), 142.39 (C-1), 158.69 (C-4a), 159.86 (C-9), 172.76 
(C=O), 195.27 (C-3). IR (KBr 1%): Ȟ = 3074, 2964, 2935, 2875, 2836, 1742, 1623, 1606, 1592, 
1538, 1485, 1461, 1443, 1431, 1364, 1296, 1229, 1216, 1163, 1139, 1096, 1056, 1025, 1008, 982, 
917, 870, 838, 803, 706 cm-1. HRMS (ESI) for C19H19O4S [M++H]: calculated 343.10047, found: 
343.10074. 
 
2.12. Photolysis general  
A 1 u 10-4 M methanol or acetonitrile/HEPES (80:20) solution of compounds 7-15 (5 mL) were 
placed in a quartz tube and irradiated in a Rayonet RPR-100 reactor at the desired wavelength. The 
lamps used for irradiation were of 254, 300, 350 and 419 ± 10 nm. HEPES buffer solution was 
prepared in distilled water with HEPES (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid) (10 
mM), sodium chloride (120 mM), potassium chloride (3 mM), calcium chloride (1 mM) and 
magnesium chloride (1mM) and pH adjusted to 7.2 with aqueous 1 M sodium hydroxide solution. 
Aliquots of 100 µL were taken at regular intervals and analysed by RP-HPLC using a Licrospher 100 
53  ȝP FROXPQ LQ D -$6&2 +3/& V\VWHP FRPSRVHG E\ D 38-2080 pump and a UV-2070 
detector with ChromNav software. The eluent was acetonitrile/water, 75:25 at a flow rate of 0.8 
mL/min, previously filtered through a Millipore, type HN 0.45 µm filter and degassed by ultra-sound 
for 30 min. The chromatograms were traced by detecting UV absorption at the wavelength of 
maximum absorption for each compound (retention time: 7, 5.2; 8, 8.7; 9, 6.1; 10, 6.6; 11, 6.5; 12, 
8.4; 13, 9.4; 14, 10.4; 15, 8.5 min). 
 
2.13. Time-resolved fluorescence measurements 
Time-resolved fluorescence measurements with one photon excitation made use of the time-
correlated single-photon counting (TCSPC) technique and were performed using a HORIBA 
Scientific DeltaFlex, equipped with a DeltaDiode laser excitation source emitting at 378 nm and a 
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PPD-850 detector. Analysis of each dataset was performed using DAS6 software and the decays 
were reconvoluted with the instrumental response and fitted to the sum of exponentials (equation 1).  
 
              (1) 
 
Where Di are the normalised pre-exponential factors and the average lifetime was obtained from 
Wave =  6DiWi            (2) 
The goodness of fit was judged in terms of a chi-squared value and weighted residuals.  
Two-photon excitation (TPE) TCSPC measurements were performed using Ti:sapphire 80MHz 
pulsed laser (Chameleon®, Coherent, UK) equipped with a pulse selector (A.P.E. PulseSelect) 
picking 1:20 pulses generating an emission train at 4MHz. The fluorescence was recorded using a 
Horiba Scientific FluoroCube synchronized to the pulse train by the driving unit of the pulse selector. 
The emission signal was recorded using a blue green copper sulphate bandpass filter. The detector 
used was a Horiba Scientific TBX-850 and data were analysed in a similar manner to the one photon 
excitation data using DAS6 software. The TPE cross-sections, expressed in Göppert-Meyer units 
(GM) with 1 GM = 10
-50
cm
4
 s photon
-1
 [27], were calculated relative to a reference fluorophore in a 
manner that we have previously reported [28]. Briefly to obtain the raw data the Ti:sapphire laser 
was tuned from 690nm to 850nm and the counts-per-second on the Horiba TBX detector recorded.  
 
 
3. Results and discussion 
 
3.1. Synthesis of butyric acid conjugates 7-15  
Butyric acid was chosen as a model carboxylic acid drug to study the behaviour towards irradiation 
of the corresponding cages with several light sensitive o-nitrobenzyl or heterocyclic benzyl type 
esters 7-12. Their synthesis started with the preparation of the 2-nitrobenzyl ester cage 7, by a 11¶-
dicyclohexylcarbodiimide (DCC)/1-hydroxybenzotriazole (HOBt) mediated coupling of butyric acid 
with (2-nitrophenyl)methanol 1 in DMF at room temperature. For the assembly of the heterocyclic 
benzyl type ester cages 8-12, several bromo- or chloromethylated heteroaromatics based on acridine 
2, naphtho[2,1-b]pyran 3-5 and a 3H-benzopyran fused julolidine 6 were reacted with the model acid 
in the presence of potassium fluoride in DMF at room temperature (Scheme 1, Table 1). Fused 
pyrans 3-6 resulted from a Pechmann condensation between ethyl 4-chloro-3-oxobutanoate and 3-
methoxy-2-naphthol, 6-methoxy-2-naphthol, 7-methoxy-2-naphthol [25] and 1,2,3,5,6,7-
i
n
1i
i ĲtexpĮI(t)  ¦ 
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hexahydropyrido[3,2,1-ij]quinolin-8-ol (trivially named 8-hydroxyjulolidine) [26], respectively. 
With the purpose of replacing the carbonyl by a thiocarbonyl group at the naphtho[2,1-b]pyran 
conjugates 9-11 WKHVH FRPSRXQGV ZHUH UHDFWHG ZLWK /DZHVVRQ¶V UHDJHQW LQ WROXHQH XQGHU UHIOX[
conditions [29], affording the corresponding thionaphthopyran conjugates 13-15. 
 
< Scheme 1> 
< Table 1> 
 
All compounds were fully characterised by high resolution mass spectrometry, IR, 1H and 13C NMR 
spectroscopy. The IR spectra of compounds 7-15 displayed stretching vibration bands of the ester 
carbonyl group from 1711 to 1743 cm-1. 1H NMR spectra showed signals of butyric acid, the methyl 
(į 0.89-1.02 ppm) and two methylenes (į 1.58-1.81 and 2.32-2.50 ppm). The heterocycle methylene 
group, adjacent to the ester link, was visible for all compounds (į5.20-6.12 ppm). The newly formed 
ester linkages were confirmed by 13C NMR spectra signals of the carbonyl group, at about į 172.52-
173.42 ppm. The thiocarbonyl group in compounds 13-15 affected the chemical shift of the pyran 
proton H-2, which appeared downfield in the range į 7.51-7.59 ppm, while in the precursor 
compounds 9-11, with a carbonyl group, it occurred at į 6.58-6.70 ppm. The presence of the new 
C=S bond (C-3) at the heterocyclic ring was also confirmed by 13C NMR spectra signals at į 194.49-
195.27 ppm, when compared to the carbonyl group, which occurred at į 159.43-160.31 ppm. The 
chemical shift of the pyran carbon C-2 was also influenced by the carbon-sulphur double bond, being 
in the range į 126.97-127.80 ppm for compounds 13-15, and į 112.72 or 113.14 ppm for compounds 
9-11.  
 
 
3.2. Evaluation of the photophysical properties of butyric acid conjugates 7-15  
Fundamental UV/visible photophysical characterisation was carried out to obtain the parameters 
required for monitoring the photolytic process. The absorption and emission spectra of degassed 10-5 
M solutions in absolute ethanol, a methanol/HEPES and acetonitrile/HEPES buffer (80:20) solutions 
of ester conjugates 7-15 were measured and the corresponding data, absorption and emission 
maxima, molar absorption coefficients and relative fluorescence quantum yields are reported in 
Table 1. Relative fluorescence quantum yields were calculated using 9,10-diphenylanthracene in 
ethanol ()F 0.95) [30] or a 0.05 M solution of quinine in sulphuric acid ()F 0.546) [31] as standards. 
For the ĭF determination, the fluorescence standard was excited at the wavelengths of maximum 
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absorption found for each compound to be tested and in all fluorimetric measurements the 
absorbance of the solution did not exceed 0.1.  
Regarding the maximum absorption wavelengths (Ȝabs) of conjugates 7-15, in all the tested solvents, 
it was found that the nitrobenzyl conjugate 7 displayed the lowest values (at about 260 nm), in 
comparison with the polycyclic compounds 8-12 (344-394 nm), whereas the thiocarbonyl conjugates 
13-15, displayed even larger bathochromic shifts (404-431 nm). For naphtho[2,1-b]pyrans 9-11, 
which differ in the relative position of the electron donor methoxy group, the Ȝabs was longer for 
substitution in position 8 (compound 10), with a bathochromic shift between 15 to 23 nm, when 
compared with substitution in positions 5 and 9 (compounds 9 and 11, respectively). Nevertheless, 
the largest shift was observed for the 3H-benzopyran fused julolidine 12, with maximum absorption 
wavelengths in the range 394-399 nm, in the various solvents. Furthermore, the replacement of the 
carbonyl group in the pyran ring (compounds 9-11) by a thiocarbonyl (compounds 13-15) also 
resulted in a shift in the Ȝabs, by tuning absorption to values in the visible region (Ȝabs 404-431 nm).  
Concerning the fluorescence spectra, in all the tested solvents, it was observed that emission maxima 
(Ȝem) of conjugates 8-15 occurred in the range (410-497 nm), being the 3H-benzopyran fused 
julolidine 12 associated to the longer wavelengths, and the naphtho[2,1-b]pyran 10 the most emissive 
()F 0.45 to 0.53). The nitrobenzyl conjugate 7 displayed the lowest values (Ȝem at about 300 nm), as 
was expected due to its structure. The emission of thiocarbonyl conjugates 13-15 was 
hypsochromically shifted with lower fluorescent quantum yields, in comparison with the 
corresponding carbonyl precursors. 
 
3.3. Photolysis studies of butyric acid conjugates 7-15 
The present work intended to profit from our gathered knowledge in the application of different 
(hetero)aromatic benzyl type systems as photoremovable protecting groups for a variety of relevant 
biomolecules. In particular, our previous findings in the photolytic release of butyric acid from 
different naphthoxazole, naphthopyran and oxazole fused pyran cages, revealed that these 
heterocyclic systems were promising mainly at short wavelengths. In order to develop a system that 
allows the delivery of butyric acid at longer wavelengths, heterocyclic compounds that showed 
interesting results with other biomolecules, as previously reported [16,18,24], as well as new 
naphthopyrans methoxylated at different positions of the polycyclic ring, and the corresponding 
thionated derivatives were used in the caging of butyric acid. Photolytic studies of all the ester cages 
7-15 were carried out in a Rayonet RPR-100 reactor at 254, 300, 350 and 419 nm in mixtures of 
methanol or acetonitrile with aqueous HEPES buffer in 80:20 solutions, with collection of kinetic 
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data. The course of the photocleavage reaction was followed by reverse phase HPLC with UV 
detection. The plots of peak area (A) of the starting material versus irradiation time were obtained for 
each compound, at the considered wavelengths. Peak areas were determined by HPLC, which 
revealed a gradual decrease with time, and were the average of three runs. The determined irradiation 
time represents the time necessary for the consumption of the starting materials until less than 5% of 
the initial area was detected (Table 2). For each compound and based on HPLC data, the plot of ln A 
versus irradiation time showed a linear correlation for the disappearance of the starting material, 
which suggested a first order reaction, obtained by the linear least squares methodology for a straight 
line. The photochemical quantum yields (ĭPhot) were calculated based on half-lives (t1/2), molar 
absorptivities (H) and the incident photon flux (I0), which was determined by potassium ferrioxalate 
actinometry [30].  
The results at various wavelengths of irradiation revealed the significant influence of the photoactive 
unit structure in the irradiation time (tirr) necessary to release butyric acid (Table 2). Although a study 
at short wavelengths (254 and 300 nm) was carried out for comprehensiveness and the results are 
included in Table 2, the main focus of the present work was the performance at 350 and 419 nm. At 
these wavelengths, considering the nitrogen heterocyclic system, namely acridine cage 8, it was 
found that the release occurred with very short tirr in methanol/HEPES when compared to 
acetonitrile/HEPES, which suggested the influence of the organic solvent character in this 
photoreaction. For the remaining oxygen heterocyclic conjugates, naphtho[2,1-b]pyrans 9-11, 
irradiation times were comparable in both solvent systems, with compound 9 cleaving faster at 350 
nm and compound 11 at 419 nm, which can be related to the position of the methoxy substituent.  
However, the best results were obtained with the 3H-benzopyran fused julolidine 12, at both 
wavelengths and solvent systems, as butyric acid was completely released within 4 to 6 min of 
irradiation. The bathochromic shift in the maximum absorption wavelengths related to the presence 
of the thiocarbonyl group in cages 13-15 lead to significantly shorter irradiation times at 419 nm due 
to an increase in the efficiency of the photolysis, in comparison to the carbonyl precursors 9-11, as 
expected. 
 
<Table 2> 
 
 
Additionally to monitoring the photolysis process by HPLC/UV detection, the release of butyric acid 
was also followed by 1H NMR in an acetonitrile-d3/D2O (80:20) solution.  Upon irradiation at 419 
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nm of a solution of 3H-benzopyran fused julolidine cage 12, the signal due to the benzylic-type CH2 
at position 9 of the heterocyclic ring, visible at about į 5.17 ppm gradually decreased with time. The 
same observation occurred with the signals related to the butyric acid in the conjugated form at about 
į2.45, 1.65 and 0.95 ppm, giving rise to a close set of signals corresponding to butyric acid in its 
free form at about į 2.10, 1.55 and 0.90 ppm, respectively (Figure 1). NMR monitoring was carried 
out with a 1.17 × 10-2 M solution, which led to an expected increase in the photolysis time for the 
complete release of the molecule, when compared to the irradiation times in Table 2 obtained with 
dilute solutions. 
 
3.4. Time-resolved studies of butyric acid conjugates 8-15 
To help elucidate the photophysical processes occurring in these compounds time-resolved 
fluorescence measurements were performed on samples that were freshly prepared (after an initial 
check of the absorption and emission steady state spectra). To facilitate future (accessible using 2-
photon excitation) studies, an excitation wavelength of 378nm for the compounds in 
acetonitrile/HEPES buffer (80:20) solution was chosen. This wavelength is between the two longer 
ones employed in the photoreactor and provides an excitation into the main absorption bands for 
each of the compounds. Measurements were made close to the peak emission and in every case the 
decay was found to require the sum of 3 exponential components (apart from 2 exponentials for 8). 
This is indicative of the presence of different excited state species and the outcome of these 
measurements is presented in Table 3. The behaviour seen is in keeping with our previous 
observations [19,20,26] and the longer-lived emission can relate to unquenched fluorophore. The 
shorter-lived decays are attributed to charge transfer states, caused by the presence of the conjugate 
upon excitation, with the possibility of the formation of an ion pair that can either recombine or 
progress to a cleaved pair. Thus, the contribution of each of the fluorescing components gives an 
insight into the species present.  
Here we aim to ascertain if the fluorescence lifetime can help provide complementary information to 
that of the photolysis study and assume that the amount of photocleavage during the measurement is 
not too significant. From Table 3 it can be noted that the compound giving the highest photochemical 
yield (12) also exhibits the shortest average lifetime, showing that overall the non-radiative 
processes, ie charge transfer, can be higher in this compound. On the other hand, compound 8, 
considering the 350 nm values in Table 2, has one of the lowest photochemical yields and exhibits 
the longest-lived average lifetime. It is a moot point in this case whether the quantity of the longest-
lived component relates to cleaved photoproduct, as we have previously shown using decay 
associated spectra and a kinetic measurement [26], or can reflect on the strength of coupling to the 
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conjugate. This will be the basis of further work, although the fact that 12 exhibits a high 
photochemical yield, while displaying the shortest average lifetime may indicate the latter. Here the 
photophysics will be used to assess the effect of treatment of Lawesson¶s reagent (ie comparison of 
9,10,11 with 13,14,15 respectively). Considering the data in Table 3, it does not appear that 
treatment dramatically affects the lifetime values, minor changes are observed and their trend 
between compounds similar before and after treatment with /DZHVVRQ¶Vreagent. However there are 
some differences in the contribution of the lifetimes to the overall emission. It would appear that the 
use of /DZHVVRQ¶V reagent has generally had the desired effect of enabling longer wavelength 
irradiation to be employed without significantly altering the photophysics of these compounds. 
Having established that longer wavelength excitation could be employed, and since this fits within 
the wavelength range of Ti:sapphire lasers making use of two-photon excitation, a study was 
performed to ascertain the compounds two-photon absorption cross-section. Initially to investigate 
the extent of two-photon excitation the relation between the fluorescence intensity and the excitation 
power was plotted. Figure 2a shows an example of the intensity squared dependence of the 
fluorescence signal form the measurement of compound 11. The slope of the curve lies close to 2, 
which is indicative of a two-photon excitation process. Measurements for the other compounds 
yielded similar dependencies between the fluorescence intensity and the excitation power. An 
example of a decay measurement (this time compound 10) obtained using 750 nm excitation is 
shown in Figure 2b. The lifetime values recovered (W1 = 378 ± 56 ps, D1 = 0.29; W2 = 4948 ± 174 ps, 
D2 = 0.44; W3 = 9635 ± 84 ps, D3 = 0.27) are in keeping with those obtained from the one-photon 
excitation measurement. It should be noted that the pulses appearing in the instrumental response 
arise from suppression of the fundamental 80MHz pulse train by the pulse picker. Their presence has 
been reduced to ~1% of the principal pulse and appear accounted for in the fitting process, as judged 
by the weighted residuals.  
 
<Figure 2> 
 
To further characterise their suitability the two-photon absorption cross-section were obtained, and 
these are given in Figure 3. The probability for two-photon-excitation (TPE) depends on both spatial 
and temporal overlap of the incident photons. TPE spectra will usually differ from one-photon 
spectra as transitions that are forbidden in one case may be allowed in the other [33]. The cross 
sections for TPE are usually small and very high photon flux is needed for excitation. The measured 
GM for different fluorophores can range from 1 to 1000 GM [34]. From Figure 3, peak values of 
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about 8 GM for compounds 10 and 11 are obtained. Weaker cross-sections are obtained for the 
FRPSRXQGV WUHDWHG ZLWK /DZHVVRQ¶V UHDJHQW ZLWK 73( FKDUDFWHULVWLFs reaching up to 2, although 
their spectral response extends to longer wavelengths. However, it should also be noted that because 
of the uncertainty reported for the reference values [35] and subsequent error progression in the 
calculation these values should be treated as good estimates.  Nevertheless, TPE cross-sections 
falling in the range of 1 to 10 GM are in good agreement with commonly used dyes [34, 36], 
although weaker than those exhibited by engineered fluorescent proteins [33].  Thus it is apparent 
that these compounds are indeed suitable for two-photon excitation. 
 
<Figure 3> 
 
 
 
4. Conclusions  
 
Acridine, naphtho[2,1-b]pyran, 3H-benzopyran fused julolidine and thioxo-naphtho[2,1-b]pyran 
ester cages of butyric acid were studied for the controlled delivery of the active molecule by 
photolysis at selected wavelengths (254, 300, 350 and 419 nm), in comparison with the well-known 
o-nitrobenzyl photolabile group. Irradiation was carried out in a Rayonet RPR-100 photochemical 
reactor in mixtures of organic solvents (methanol or acetonitrile) with aqueous HEPES buffer and 
monitored by HPLC-UV and 1H NMR. Overall, the obtained results, combined with time-resolved 
fluorescence data, showed that for naphtho[2,1-b]pyrans the attachment position of the methoxy 
substituent as well as the presence of the thiocarbonyl group influenced the behaviour towards light 
of the corresponding cage. Furthermore, the release of butyric acid was faster in the case of using 
(acridin-9-yl)methyl, and [11-oxo-2,3,5,6,7,11-hexahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-
9-yl]methyl (3H-benzopyran fused julolidine) groups as phototriggers. The suitability to be 
addressed using two-photon excitation was also demonstrated with promising TPE cross-sections. 
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CAPTIONS 
 
Figure 1. Partial 1H NMR spectra in acetonitrile-d3/D2O (80:20) of the photolysis of 3H-benzopyran 
fused julolidine 12 (C = 1.17 × 10-2 M) at 419 nm: (a) before irradiation; (b) after irradiation for 4 h; 
(c) after irradiation for 10 h; (d) butyric acid. 
 
 
Figure 2. (a) Plot of intensity against power, showing the data for compound 11 and the slopes 
calculated for all the compounds. The values obtained (error within 15%) close to 2 showed a 
quadratic dependency and are demonstrative of a two-photon process. (b) Fluorescence decay (from 
10) showing the instrumental response, decay, fitted function (3 exponential) and weighted residuals. 
Note that the pulse selection process has left the fundamental (80MHz) train suppressed to a level 
~1% that of the selected pulse. 
 
 
Figure 3. Plot of the two-photon excitation cross-sections versus wavelength for the different 
compounds. 
 
 
Table 1. Yields, UV/visible absorption and fluorescence data for compounds 7-15 in absolute 
ethanol, methanol/HEPES buffer (80:20) and acetonitrile/HEPES buffer (80:20) solutions. 
a in nm. b Data in ethanol and methanol/HEPES buffer (80:20) solution was previously reported [20]. 
c The excitation was carried out at 326 nm. 
 
 
Table 2. Irradiation times (tirr in min), and photochemical quantum yields (ĭPhot, u 10-3) for the 
photolysis of conjugates 7-15 at 254, 300, 350 and 419 nm in methanol/HEPES buffer (80:20) and 
acetonitrile/HEPES buffer (80:20) solutions. a Data in ethanol and methanol/HEPES buffer (80:20) 
solution was previously reported [20]. 
 
Table 3. Time-resolved fluorescence decay parameters, lifetime (Wi, in ps), and normalised pre-
exponential values (Di), calculated average lifetime and goodness of fit (F2), for compounds 8-15 in 
acetonitrile/HEPES buffer (80:20). The excitation wavelength was 378 nm and the emission 
wavelengths (Oem) are also in nm. 
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Scheme 1. Synthesis of ester cages of butyric acid 7-15. Reagents and conditions: a) DCC/HOBt, 
DMF, rt; b) KF, DMF, rt;  c) /DZHVVRQ¶VUHDJHQWWROXHQH reflux.
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TABLES 
Table 1.  
 
 
 
 
 
Compd 
Yield 
(%) 
Ethanol Methanol/HEPES (80:20) Acetonitrile/HEPES (80:20) 
Ȝabsa log İ Ȝema ĭF 'Ȝa Ȝabsa log İ Ȝema ĭF 'Ȝa Ȝabsa log İ Ȝema ĭF 'Ȝa 
7 29 256 3.77 303 0.08 47 259 3.73 304 0.07 45 260 3.74 304 0.13 44 
8 69 360 3.71 410 0.34 50 360 4.12 427 0.32 67 360 4.15 427 0.27 67 
9 70 344 3.54 464 0.18 120 343 3.93 479 0.21 136 343 3.96 472 0.20 129 
10 71 
316, 
365 
4.07, 
3.85 
459 0.53 94 
316, 
366 
3.99, 
3.80 
470 0.49 104 
314, 
364 
4.18, 
3.97 
464 0.45 100 
11b 80 350 3.92 466 0.45 116 352 4.22 484 0.46 132 345 3.86 474 0.40 129 
12 34 394 4.28 485 0.19 91 399 4.13 497 0.16 98 397 4.06 494 0.18 97 
13 5 
310, 
404 
3.83, 
3.70 
447 0.03 43 
308, 
406 
3.94, 
3.86 
448 0.03 42 
308, 
405 
4.04, 
3.95 
437 0.03 32 
14c 80 
283, 
326, 
431 
4.19, 
4.28, 
4.21 
464 0.06 138 
326, 
428 
4.15, 
4.12 
477 0.05 151 
326, 
430 
4.26, 
4.23 
466 0.01 140 
15 70 407 4.20 462 0.002 55 412 3.97 470 0.001 58 412 4.21 470 0.001 58 
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Table 2.  
Compound 
Methanol/HEPES (80:20) Acetonitrile/HEPES (80:20) 
254 nm 300 nm 350 nm 419 nm 254 nm 300 nm 350 nm 419 nm 
t
irr
 )Phot tirr )Phot tirr )Phot tirr )Phot tirr )Phot tirr )Phot tirr )Phot tirr )Phot 
7 11 1.71 26 0.37 76 0.12 2217 0.004 14 1.49 41 0.225 106 0.085 1198 0.008 
8 4 1.88 7 0.60 2 1.64 83 0.044 58 0.129 120 0.03 328 0.011 2499 0.001 
9 192 0.063 230 0.027 182 0.033 5985 0.001 186 0.062 184 0.033 172 0.031 4288 0.001 
10 432 0.039 546 0.015 555 0.014 3324 0.0024 457 0.025 481 0.012 493 0.012 9989 0.001 
11a 178 0.034 253 0.011 263 0.011 490 0.006 278 0.054 294 0.024 270 0.026 520 0.013 
12 6 1.41 9 0.426 6 0.79 5 0.790 5 1.87 7 0.691 4 1.04 4 1.03 
13 55 0.262 178 0.039 210 0.032 142 0.047 53 0.202 129 0.044 292 0.018 193 0.029 
14 212 0.040 371 0.001 526 0.007 351 0.010 153 0.042 585 0.005 308 0.010 296 0.010 
15 90 0.129 184 0.029 296 0.018 98 0.129 57 0.114 111 0.020 203 0.023 76 0.040 
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Table 3. 
 
compound Oem W1 W2 W3 D1 D2 D3 Wave F2 
8 410 511 ± 60 10791 ± 27  0.31 0.69  7655 0.98 
9 475 113 ± 39 2631 ± 507 3591 ± 75 0.24 0.34 0.42 2416 1.14 
10 460 155 ± 150 4954 ± 174 10379 ± 67 0.13 0.53 0.34 6121 1.08 
11 470 65 ± 39 3522 ± 543 7208 ± 33 0.38 0.09 0.53 4142 1.09 
12 470 240 ± 30 2241 ± 99 5108 ± 60 0.46 0.35 0.19 1835 1.20 
13 470 216 ± 54 2991 ± 75 5831 ± 175 0.28 0.64 0.08 2434 1.16 
14 470 91 ± 39 4812 ± 162 10065 ± 93 0.42 0.35 0.23 4100 1.08 
15 470 118 ± 129 2445 ± 339 6893 ± 24 0.25 0.11 0.64 4701 1.10 
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Figure 1. 
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Figure 3. 
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SCHEMES 
Scheme 1.  
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